guidance and direction of their faculty mentors [13] . Several excellent tools iv exist to assess these team skills and provide students the opportunity for self-and peer evaluation and reflection [14] .
Concluding Remarks
If synthetic biology is to maintain its distinctive culture of collaboration and its openness to sharing and to innovation, it is up to us to instill these values in the students we teach. In this way we can cultivate a new generation of synthetic biologists who will hold true to its founding principles and will be positioned to evolve with this burgeoning and unique discipline. 
The Problem with the Current EU GMO Legislation
Annex 1B of the EU Directive 2001/18/EC lists techniques, such as mutagenesis, resulting in GMOs that are excluded from regulation by the Directive. There are two problems here: the Directive contains no definition of mutagenesis, and the definition of GMO is somewhat ambiguous because it refers to an organism 'in which the genetic material has been altered in a way that does not occur naturally'. Another complicating factor is that the national translations of the Directive contain wording regarding the definitions of GMO and mutagenesis that may differ in interpretation, and an attempt at harmonization would be desirable. A common interpretation among the scientific community of the GMO definition, shared by us and others [2] , is that a certain technique may serve as a trigger for the classification as GMO, but that a certain outcome regarding the product (i.e., the presence of a novel combination of stably inherited recombinant nucleic acids) is also required for an organism to be regulated under Directive 2001/18/EC. However, not all stakeholders agree with this interpretation, hampering the political progress to decide on the regulation of NPBTs.
A Proposal to Amend the EU GMO Directive
The Dutch proposal does not seek to reconcile the different interpretations of the GMO definition per se, but merely recommends a set of criteria to replace the list of techniques in Annex 1B (Box 1). Not all products resulting from the use of NPBTs would be exempted; instead, exemption would be based on the dual condition that: (i) the resulting organism does not contain recombinant nucleic acids; and (ii) no genetic material other than what could be exchanged through traditional breeding methods is introduced. It is not the first proposal of this kind to originate from The Netherlands. In 2006, a team at Wageningen University and Research [3] suggested that cisgenesis, one of the eight NPBTs mentioned in a report requested by the EU [4] , should be listed among the exemptions in Annex 1B. The new proposal is also consistent with several reports delivered by The Netherlands Commission on Genetic Modification (COGEM) [5] [6] [7] .
Examples from Public Research Institutes
We, being publicly funded academic researchers, welcome the intentions of the Dutch proposal because we acknowledge that periodically updating the regulatory framework is instrumental in responding to technical progress. Here, we present examples of publicly funded research, from our own or other institutes, resulting in applications that may be affected by the proposal if it were to be adopted into EU legislation. 
Sweden
Genome editing is applied on potato via the transfection of protoplasts and subsequent regeneration of plants, to produce tubers with an improved starch quality for industrial extraction. CRISPR/Cas9 and doublestranded breaks with nonhomologous end-joining (NHEJ) are utilized to achieve mutations and enzyme function knockout, and successful multiallelic mutations in regenerated potato plants have been demonstrated [10] . The resulting genetic . Nearly 30 years of technical progress is arguably a compelling reason to endow the current Directive with such a mechanism. When the GMO Directive was developed, transgenesis mainly aimed at ectopic expression of foreign genes, whereas techniques such as genome editing or RNA interference were not yet developed. Today, researchers and breeders use these and other new breeding techniques, such as synthetic oligonucleotides or optimized alleles with very high similarity to endogenous sequences, to alter the sequence or expression patterns of endogenous genetic material in more subtle ways. Additionally, horizontal gene transfer occurs commonly in nature, and genotypes of a given species can display more dissimilar genomes than may have been thought previously.
alterations are not of recombinant type and would not be regulated as GMO.
UK: England
Targeted gene knockouts are produced using RNA-guided Cas9 in a range of crops, including barley, wheat, Brassica oleracea, Brassica napus, potato, and tomato. This technology is valuable for research on abiotic stress tolerance, disease resistance, aspects of plant development, nitrogen use efficiency, and food and feed quality. There are also real opportunities for crop improvement. One example is B. oleracea, where CRISPR/Cas9 has been used to produce edited plants with shatter-resistant pods to reduce losses during harvest (Figure 1 ) [11] . In the cereals, there is the potential to engineer drought tolerance through specific mutations that will affect the regulation of transcription factors involved in the stress response. These mutations would also, with the Dutch proposal, lead to organisms that are not regulated as GMOs.
UK: Wales
Lolium perenne, an important forage and turf grass, has never been domesticated to lose its innate seed-shattering phenotype. This is a major yield constraint for the producers of certified seed, who currently must harvest the seeds before they are fully mature or use other expensive recovery methods. Homologs of shattering genes are identified in L. perenne and single base-pair substitutions yield a nonshattering phenotype. Grasses are outbreeding polyploids that are bred as families rather than as individuals, which makes this trait intractable using conventional methods. This breeding bottleneck is being overcome by using CRISPR/ Cas9 gene editing to make this conversion in elite L. perenne germplasm, without introducing any recombinant nucleic acids.
Complications and Prospects
Although would provide necessary clarification beyond doubt for all stakeholders.
The proposal is not free from complications. Some stakeholders are reluctant to open up the EU GMO legislation for amendments, because such a process could take many years, during which the plant research and breeding sector would lack a clear vision for commercial applications. Opening up the Directive might also lead to increased regulation of so-called 'conventional breeding techniques', which would be detrimental to the entire seed sector. The proposal may be untimely because all attention is presently directed towards a European Court of Justice case on mutagenesis (C528/16), which may be decisive for certain applications of genome editing [12] . However, this court case is limited in scope and will not resolve the issue of NPBTs other than applications of nuclease-or nucleotide-directed mutagenesis. It is also argued that amending Annex 1B is unnecessary since, according to a common interpretation, Directive 2001/ 18/EC is already sufficiently clear to manage NPBTs. However, more than 10 years of discussions demonstrate that this is not the case. Although it may still suffer from shortcomings, the Dutch proposal is a welcome approach to initiate a dialog at the EU level and may offer the possibility for the research at our institutes, together with many others, to deliver benefits to farmers, the environment, and society.
